A detailed history of Level Four Advisory Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 24,391 shares of ABT stock, worth $2.87 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
24,391
Previous 23,436 4.07%
Holding current value
$2.87 Million
Previous $2.44 Million 14.17%
% of portfolio
0.12%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $95,566 - $112,814
955 Added 4.07%
24,391 $2.78 Million
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $5.14 Million - $5.74 Million
-51,065 Reduced 68.54%
23,436 $2.44 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $293,388 - $359,131
3,253 Added 4.57%
74,501 $8.2 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $5.64 Million - $6.77 Million
-59,062 Reduced 45.32%
71,248 $6.9 Million
Q2 2023

Jul 10, 2023

SELL
$100.78 - $112.29 $2.89 Million - $3.22 Million
-28,707 Reduced 18.05%
130,310 $14.2 Million
Q1 2023

Jun 05, 2023

BUY
$96.86 - $114.01 $7.89 Million - $9.28 Million
81,436 Added 104.97%
159,017 $16.1 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $4.72 Million - $5.53 Million
49,604 Added 177.3%
77,581 $8.52 Million
Q3 2022

Nov 07, 2022

SELL
$96.76 - $112.03 $220,516 - $255,316
-2,279 Reduced 7.53%
27,977 $2.71 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $46,952 - $56,750
-460 Reduced 1.5%
30,256 $3.29 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $36,030 - $43,936
316 Added 1.04%
30,716 $3.64 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $1.78 Million - $2.17 Million
15,364 Added 102.18%
30,400 $4.28 Million
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $1.27 Million - $1.41 Million
-10,907 Reduced 42.04%
15,036 $1.78 Million
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $30,044 - $35,366
-284 Reduced 1.08%
25,943 $3.01 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $367,770 - $433,289
-3,379 Reduced 11.41%
26,227 $3.14 Million
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $25,620 - $27,918
-244 Reduced 0.82%
29,606 $3.24 Million
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $45,911 - $55,756
-501 Reduced 1.65%
29,850 $3.25 Million
Q2 2020

Aug 17, 2020

BUY
$76.57 - $98.0 $2.32 Million - $2.97 Million
30,351 New
30,351 $2.78 Million
Q2 2020

Jul 27, 2020

SELL
$76.57 - $98.0 $2.04 Million - $2.62 Million
-26,690 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $104,406 - $152,671
-1,662 Reduced 5.86%
26,690 $2.1 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $151,759 - $168,944
1,933 Added 7.32%
28,352 $2.46 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $28,562 - $30,970
-349 Reduced 1.3%
26,419 $2.21 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $135,848 - $158,440
1,864 Added 7.48%
26,768 $2.25 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $53,505 - $64,688
-808 Reduced 3.14%
24,904 $1.99 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $56,971 - $64,540
869 Added 3.5%
25,712 $1.86 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $5,412 - $6,529
89 Added 0.36%
24,843 $1.82 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $32,124 - $35,455
558 Added 2.31%
24,754 $1.51 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $19,469 - $22,012
346 Added 1.45%
24,196 $1.45 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $64,254 - $68,791
1,197 Added 5.28%
23,850 $1.36 Million
Q3 2017

Apr 03, 2018

SELL
$48.06 - $53.64 $63,439 - $70,804
-1,320 Reduced 5.51%
22,653 $1.21 Million
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $308,785 - $344,637
6,425 Added 36.61%
23,973 $1.31 Million
Q2 2017

Sep 20, 2017

SELL
N/A
-702 Reduced 3.85%
17,548 $769,000
Q1 2017

Sep 20, 2017

BUY
N/A
18,250
18,250 $800,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.